Nine recommendations for extending therapeutic indications reflect ongoing lifecycle management and utility expansion of ...
Priority Review was granted by FDA for the first line metastatic TNBC treatment. Datroway significantly improved survival ...
In this forward-looking whitepaper, Blue Mountain explores how agentic AI —autonomous, context-aware AI agents—could ...
In this forward-looking whitepaper, Blue Mountain explores how agentic AI —autonomous, context-aware AI agents—could ...
Cellares is partnering with Stanford Medicine to automate gene-edited stem cell therapy for HIV and more than 19 rare diseases.
Dr. Stacy Lindborg is president and CEO of IMUNON, a clinical-stage company in phase 3 development with a lead DNA-mediated immunotherapy for advanced ovarian cancer. Dr. Lindborg has worked in the ...
Currently, USP standards are utilized in 22,000 manufacturing facilities across 140 countries. Because of this massive scale, even small updates to these standards—such as those coordinated with the ...
EMA recommends Kygevvi for rare thymidine kinase 2 deficiency. It is the first authorized treatment for this disease.
FDA Commissioner Marty Makary, M.D., M.P.H., characterized the program as a “bold step” to bring manufacturing back to the US and make the domestic sector more resilient and competitive. This program ...
EMA recommends Rezurock (belumosudil) for chronic graft-versus-host disease, with the drug. Meetings unmet needs via ...
Financial support and mentorship are crucial for encouraging women to consider STEM careers, bridging the gap in ...
Halo Pharma's transition to a standalone CDMO allows a concentrated focus on drug product services, enhancing technical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results